Rebecca Bakker-Arkema

AlphaCore Pharma LLC engages in pharmaceutical research. It develops recombinant human lecithin-cholesterol acyltransferase enzyme that helps reducing cholesterol from the body. The company was founded by Reyn Homan, Bruce J. Auerbach, and Brian R. Krausen on June 20, 2007 and is headquartered in Ann Arbor, MI.

Metabasis Therapeutics, Inc. engages in discovery, development and commercialization of novel drugs for metabolic diseases using the proprietary technology and the knowledge of processes and pathways within the liver that are useful for liver-selective drug targeting and treatment of metabolic diseases. Metabasis was incorporated in April 1997 and is headquartered in La Jolla, CA.

Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI.